Am J Transplant, Volume 5, Suppl 3 Archives - Page 114 of 170 - ATC Abstracts

2015 American Transplant Congress
Somatostatin (Eumedica®) Infusion Allows Modulating Graft Flows and Gradients in Liver Transplantation. Results of a Randomized, Double Blind, Placebo Controlled Trial
R. Troisi,¹ A. Croo,¹ E. Codarin,³ E. De Wolf,¹ J. Van Limmen,⁴ G. Antoniali,³ B. Heyse,⁴ L. De Baerdemaeker,⁴ I. Colle,⁵ G. Tell,³ M. Sainz-Barriga.^1,2
¹General Hepatobiliary Surgery Liver Transplantation Service, Ghent University Hospital Medical School, Ghent, Belgium; ²Digestive Surgery & Liver Transplantation, University of Tours, Tours, France; ³Medical & Biological Sciences, University of Udine, Udine, Italy; ⁴Anesthesiology, Ghent University Hospital Medical School, Ghent, Belgium; ⁵Gastroenterology, Ghent University Hospital Medical School, Ghent, Belgium.
Background: Somatostatin (SST) infusion decrease portal pressure in acute variceal bleeding in cirrhotic patients. Despite liver transplantation (LTx), recipients with portal hypertension (PHT) display different…
2015 American Transplant Congress
Immune Phenotyping of Peripheral Blood Samples from the CTOT-10 Belatacept Study
Y. Suessmuth,¹ L. Stempora,¹ B. Johnson,¹ J. Cheeseman,¹ Y. Morrison,⁴ N. Bridges,⁴ D. Ikle,⁵ S. Tomlanovich,³ P. Stock,³ R. Mannon,² K. Newell,¹ C. Larsen,¹ A. Mehta.¹
¹Emory Transplant Center, Atlanta; ²University of Alabama, Birmingham; ³University of California San Francisco, San Francisco; ⁴NIAID/ NIH, Bethesda; ⁵Rho, Chapel Hill, NC.
The purpose of the CTOT-10 study is to evaluate belatacept as maintenance therapy, while minimizing calcineurin inhibitors and corticosteroids in renal transplantation. We designed mechanistic…
2015 American Transplant Congress
Transplant Glomerulopathy in a Novel Model of Chronic Antibody Mediated Rejection Is Associated With DSA and Glomerular IgM
S. Panzer,¹ S. Reese,¹ N. Wilson Schlei,¹ W. Zhong,² A. Djamali.¹
¹Medicine, University of Wisconsin Madison, Madison, WI; ²Pathology, University of Wisconsin Madison, Madison, WI.
PurposeChronic active antibody mediated rejection (cAMR) and transplant glomerulopathy (TG) are major determinants of long-term allograft survival. However, the contribution of DSA and glomerular immunoglobulins…
2015 American Transplant Congress
Native Americans and Post-Kidney Transplant Follow-Up: Lower in Quantity and Quality?
S. Stith,¹ F. Barrantes.²
¹Department of Economics, University of New Mexico, Albuquerque, NM; ²Renal Medicine Associates/Presbyterian Transplant Center, Albuquerque, NM.
Background: Native Americans have been shown to face decreased access to waitlisting and transplantation.They appear to have similar short-term survival prospects post-transplant to those of…
2015 American Transplant Congress
Emerging Strategies to Screen Kidney Offers Based on the Kidney Donor Profile Index (KDPI)
D. Stewart,¹ A. Kucheryavaya,¹ G. Boyle,¹ R. Metzger,^2,3 M. Aeder,⁴ R. Formica.⁵
¹UNOS, Richmond, VA; ²Florida Hosp, Orlando, FL; ³Translife, Orlando, FL; ⁴Univ Hosp Case Med Ctr, Cleveland, OH; ⁵Yale Univ, New Haven, CT.
Background: In the Organ Procurement and Transplantation Network's (OPTN) new kidney allocation system, kidney offers are screened by setting for each candidate a maximum acceptable…
2015 American Transplant Congress
Identifying Predictors for 30-Day Readmission in Renal Transplant Recipients
J. Weber,¹ B. Astor,² D. Cray,³ A. Djamali,² D. Kaufman,⁴ D. Mandelbrot,² S. Parajuli,² M. Schanning,³ E. Snyder,¹ M. Mohamed.²
¹Surgical Nursing, UW Hospital & Clinics, Madison, WI; ²Department of Medicine, UW School of Medicine & Public Health, Madison, WI; ³Business Planning & Analysis Department, UW Hospital & Clinics, Madison, WI; ⁴Department of Surgery, UW School of Medicine & Public Health, Madison, WI.
Purpose: The aim of this study is to determine risk factors associated with 30-day hospital readmissions in renal transplant recipients.Methods: This single center longitudinal study…
2015 American Transplant Congress
Medication Non-Adherence in Those Waiting for a Transplant
M. Wakefield,¹ D. Murillo,² C. Russell,³ C. Ashbaugh,¹ S. Potts,² L. Blakley,² A. Deere.¹
¹Department of Surgery, University of Missouri, Columbia, MO; ²Transplant Institute, Research Hospital, Kansas City, MO; ³School of Nursing and Health Studies, University of Missouri-Kansas City, Kansas City, MO.
Purpose: Though poor medication adherence among adult kidney transplant patients is alarmingly high with distressing consequences, no one has systematically examined medication non-adherence in those…
2015 American Transplant Congress
Mesenchymal Stem Cells (MSCs) Transfusion for Desensitization of Positive Lymphocyte Cross Match (LCM) or Panel Reactive Antibodies (PRA) Before Kidney Transplantation – Outcome of 16 Cases
G. Saadi,¹ K. Eweda,² M. Hassaballa,¹ F. Fadel,³ E. Aziz,² M. Roshdi,¹ M. El Ansary,⁴ I. Aziz,⁴ W. Ismail,⁵ A. Atef,¹ S. Hamid.⁴
¹Internal Medicine and Nephrology, Cairo University, Cairo, Egypt; ²Nephrology, Army Hospital, Cairo, Egypt; ³Pediatric Nephrology, Cairo University, Cairo, Egypt; ⁴Clinical Pathology, Cairo University, Cairo, Egypt; ⁵Pathology, Beni Sweif University, Beni Sweif City, Egypt.
Immunomodulatory function of MSCs may correct positive PRA or LCM in highly-sensitized patients. We evaluate donor specific or 3rd party MSCs transfusion in 16 patients…
2015 American Transplant Congress
HLA Matching Affects Patient Survival, Graft Survival, and Incidence of Rejection Episodes in Largest Analysis to Date
J. Weiner, Z. Cui, S. Mohan, E. Verna, A. Griesemer, J. Emond.
Columbia Center for Liver Disease and Transplantation, New York Presbyterian-Columbia University Medical Center, New York, NY.
Introduction: Though human leukocyte antigen (HLA) matching between donor and recipient affects both graft and patient survival after kidney and heart transplantation, prior analysis has…
2015 American Transplant Congress
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score
J. Lee, J. Lee, D. Joo, D. Han, M. Ju, J. Choi, S. Kim, M. Kim.
Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
BackgroundLiving donor liver transplantation (LDLT) has developed as an alternative to decease donor liver transplantation (DDLT) to overcome the critical shortage of deceased organ donations.…